Interview with Dr. Fabio Corradini
Pause momentarily cycle Obesity for a couple of posts, the truth is rather self-celebrating.
This is the first part of an interview by the Vallesina TV, which is eating habits. A short
the second part, we discuss how to behave after the debauchery of the parties.
We thank the interviewer for his willingness Sara Federici.
Link: Interview
Tuesday, December 28, 2010
Friday, December 17, 2010
What Color Tie To Wear With What Color Shirt
Cycle obesity: the benefits of loss weight
In a brief and schematic, with the loss of weight can be obtained:
- Decreased blood pressure;
- Low blood sugar in diabetics and improved glucose tolerance;
- Lower total cholesterol and LDL;
- Lowering of triglycerides;
- Increase in HDL cholesterol.
In a brief and schematic, with the loss of weight can be obtained:
- Decreased blood pressure;
- Low blood sugar in diabetics and improved glucose tolerance;
- Lower total cholesterol and LDL;
- Lowering of triglycerides;
- Increase in HDL cholesterol.
Wednesday, December 8, 2010
Toiletries Needed For Wedding
Cycle obesity: complications Cycle 2
respiratory dysfunction:
Obesity is frequently associated with numerous repsiratorie functional alterations, such as:
- Increased consumption of oxygen and carbon dioxide production at rest and exercise;
- Restriction of chest with increased respiratory load and consequent increase in the work of breathing;
- Decreased functional residual capacity and closing of small airways
- Reduction of ventilatory response to oxygen and carbon dioxide.
Exertional dyspnea is a common symptom in the obese.
gastrointestinal disorders
Among the diseases of the digestive tract, gastroesophageal reflux disease, hiatal hernia, cholelithiasis, hepatic steatosis, nonalcoholic steatohepatitis, acute diverticulitis may be treated with a significant weight loss .
Steatosis is the accumulation of intracellular lipids. It can be generalized or localized (focal steatosis). This accumulation indicates an imbalance between synthesis and secretion of triglycerides.
Alcoholism is the most common cause of fatty liver, but there is also a non-alcoholic fatty liver disease, alcohol but not related to diabetes, obesity, abnormal nutrition.
Cardiovascular
The risk increases as BMI> 27.
The clinical features most of obesity are:
- ischemic heart disease;
- cardiomyopathy of obesity;
- arterial hypertension.
respiratory dysfunction:
Obesity is frequently associated with numerous repsiratorie functional alterations, such as:
- Increased consumption of oxygen and carbon dioxide production at rest and exercise;
- Restriction of chest with increased respiratory load and consequent increase in the work of breathing;
- Decreased functional residual capacity and closing of small airways
- Reduction of ventilatory response to oxygen and carbon dioxide.
Exertional dyspnea is a common symptom in the obese.
gastrointestinal disorders
Among the diseases of the digestive tract, gastroesophageal reflux disease, hiatal hernia, cholelithiasis, hepatic steatosis, nonalcoholic steatohepatitis, acute diverticulitis may be treated with a significant weight loss .
Steatosis is the accumulation of intracellular lipids. It can be generalized or localized (focal steatosis). This accumulation indicates an imbalance between synthesis and secretion of triglycerides.
Alcoholism is the most common cause of fatty liver, but there is also a non-alcoholic fatty liver disease, alcohol but not related to diabetes, obesity, abnormal nutrition.
Cardiovascular
The risk increases as BMI> 27.
The clinical features most of obesity are:
- ischemic heart disease;
- cardiomyopathy of obesity;
- arterial hypertension.
Saturday, December 4, 2010
Acceptable Bilirubin Level
obesity: complications 1 - The metabolic syndrome - obesity
metabolic syndrome is defined as the association between impaired glucose tolerance (or diabetes mellitus type II) and insulin resistance with at least two of: Hypertension, hypertriglyceridemia, central obesity, microalbuminuria.
The fasting hyperinsulinemia predicts the onset of changes due to the metabolic syndrome (and thus the development of cardiovascular risk factors). Moreover, hyperinsulinemia in fasting and after oral glucose load in itself is predictive of coronary heart disease.
Insulin resistance is one of the fundamental changes in states of impaired glucose tolerance and diabetes mellitus type II. It translates to:
- In muscle: reduced utilization of glucose, reduction of glycogen synthesis, decreased glucose oxidation;
- In adipose tissue: reduced utilization of glucose, increased lipolysis and release of lactate;
- In the liver : increased gluconeogenesis and ketogenesis, increased extraction of free fatty acids and substrates neoglucogenetici. The increased
influx of free fatty acids to the liver contributes to the exaltation hepatic glucose production, the first expression is the fasting hyperglycemia.
On the other hand, increased concentrations of free fatty acids and their increased oxidation, result in reduced utilization of glucose in muscle, resulting in worsening of hyperglycemia.
In turn, the increased blood glucose tends to reduce tissue sensitivity to insulin, through the downstream control of GLUT-4.
(for type II diabetes have reduced insulin secretion is also required).
In individuals with the metabolic syndrome, insulin resistance and hyperinsulinemia coexist.
To identify the metabolic syndrome, it is important to note nell'anamnesi:
- Family history of obesity. Diabetes, hypertension, hyperlipidemia, gout, cardiovascular disease early;
- individual weight at birth (low birth weight = predictive of diabetes mellitus type II, macrosomia = predictor of metabolic syndrome);
- Evolution of the weight in childhood and during puberty;
- Lifestyle.
course, be investigated chemical correlates of the syndrome (impaired glucose tolerance, diabetes mellitus type II, hypertension, abnormal lipid metabolism and purine).
The first project involves minimizing the cardiovascular risk through the elimination of risk factors (eg smoking). We must then arrange to normalize the glucose metabolism, purine and lipid normalize pressure.
The weight reduction is accompanied by improvement of insulin resistance.
In particular, avoid alcohol and reduction of animal fat is effective central obesity.
metabolic syndrome is defined as the association between impaired glucose tolerance (or diabetes mellitus type II) and insulin resistance with at least two of: Hypertension, hypertriglyceridemia, central obesity, microalbuminuria.
The fasting hyperinsulinemia predicts the onset of changes due to the metabolic syndrome (and thus the development of cardiovascular risk factors). Moreover, hyperinsulinemia in fasting and after oral glucose load in itself is predictive of coronary heart disease.
Insulin resistance is one of the fundamental changes in states of impaired glucose tolerance and diabetes mellitus type II. It translates to:
- In muscle: reduced utilization of glucose, reduction of glycogen synthesis, decreased glucose oxidation;
- In adipose tissue: reduced utilization of glucose, increased lipolysis and release of lactate;
- In the liver : increased gluconeogenesis and ketogenesis, increased extraction of free fatty acids and substrates neoglucogenetici. The increased
influx of free fatty acids to the liver contributes to the exaltation hepatic glucose production, the first expression is the fasting hyperglycemia.
On the other hand, increased concentrations of free fatty acids and their increased oxidation, result in reduced utilization of glucose in muscle, resulting in worsening of hyperglycemia.
In turn, the increased blood glucose tends to reduce tissue sensitivity to insulin, through the downstream control of GLUT-4.
(for type II diabetes have reduced insulin secretion is also required).
In individuals with the metabolic syndrome, insulin resistance and hyperinsulinemia coexist.
To identify the metabolic syndrome, it is important to note nell'anamnesi:
- Family history of obesity. Diabetes, hypertension, hyperlipidemia, gout, cardiovascular disease early;
- individual weight at birth (low birth weight = predictive of diabetes mellitus type II, macrosomia = predictor of metabolic syndrome);
- Evolution of the weight in childhood and during puberty;
- Lifestyle.
course, be investigated chemical correlates of the syndrome (impaired glucose tolerance, diabetes mellitus type II, hypertension, abnormal lipid metabolism and purine).
The first project involves minimizing the cardiovascular risk through the elimination of risk factors (eg smoking). We must then arrange to normalize the glucose metabolism, purine and lipid normalize pressure.
The weight reduction is accompanied by improvement of insulin resistance.
In particular, avoid alcohol and reduction of animal fat is effective central obesity.
Subscribe to:
Posts (Atom)